dehydroabietic acid has been researched along with Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Belhassan, A; Benlyas, M; Bouachrine, M; Lakhlifi, T; Zaki, H | 1 |
Chen, H; Gu, W; Liu, QS; Sun, Y; Yang, YQ | 1 |
Chen, ZF; Fei, BL; Hui, CN; Kong, LY; Long, JY; Qiao, C; Wei, Z | 1 |
Pertino, MW; Schmeda-Hirschmann, G; Theoduloz, C; Verdugo, V | 1 |
4 other study(ies) available for dehydroabietic acid and Neoplasms
Article | Year |
---|---|
New dehydroabietic acid (DHA) derivatives with anticancer activity against HepG2 cancer cell lines as a potential drug targeting EGFR kinase domain. CoMFA study and virtual ligand-based screening.
Topics: Abietanes; Drug Delivery Systems; Early Detection of Cancer; ErbB Receptors; Hep G2 Cells; Humans; Ligands; Molecular Docking Simulation; Neoplasms; Quantitative Structure-Activity Relationship | 2021 |
Synthesis and anticancer evaluation of novel 1H-benzo[d]imidazole derivatives of dehydroabietic acid as PI3Kα inhibitors.
Topics: Abietanes; Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Humans; Molecular Docking Simulation; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors | 2020 |
Copper(II) and iron(III) complexes of chiral dehydroabietic acid derived from natural rosin: metal effect on structure and cytotoxicity.
Topics: Abietanes; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Movement; Coordination Complexes; Copper; DNA Damage; Humans; Iron; Lipid Peroxidation; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms; Oxidative Stress; Protein Carbonylation; Reactive Oxygen Species; Resins, Plant; Tumor Cells, Cultured; Wound Healing | 2021 |
Synthesis and antiproliferative activity of some novel triazole derivatives from dehydroabietic acid.
Topics: Abietanes; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Neoplasms; Structure-Activity Relationship; Triazoles | 2014 |